Craniometrix

Emerging

SF dementia care coordination platform with Johns Hopkins MIND at Home partnership; YC $6.5M with $1.9M revenue connecting patients and caregivers through virtual care navigation for Alzheimer's management.

Company Overview

About Craniometrix

Craniometrix is a San Francisco-based digital health company providing virtual dementia care coordination — connecting dementia patients, family caregivers, and healthcare providers through a telemedicine platform that delivers cognitive assessment, care planning, caregiver education, and ongoing care management for Alzheimer's and related dementia conditions. Founded by CEO Nikhil Patel and backed by Y Combinator with $6-6.5 million raised from Y Combinator, Quiet Capital, and Defy.vc, Craniometrix generated $1.9 million in revenue in 2024 and partners with the Johns Hopkins MIND at Home program — a validated community-based dementia care model developed by Johns Hopkins University School of Medicine.

Business Model & Competitive Advantage

Craniometrix's care coordination platform addresses the fragmentation of dementia care support: most families managing a dementia diagnosis navigate neurologist appointments, primary care coordination, caregiver burnout, legal planning (power of attorney, advance directives), safety modifications (home monitoring, medication management), and community support resources without a guide — each element requires separate research and provider coordination. Craniometrix's platform provides a unified care navigator relationship that coordinates across these domains: digital cognitive assessments (Craniometrix administers validated cognitive screening tools remotely), care plan development, caregiver coaching on behavioral symptoms, and referrals to vetted local dementia support resources and clinical trials.

Competitive Landscape 2025–2026

In 2025, Craniometrix competes in the digital dementia care market with DementiaMap (care navigation platform), Dementia Care Specialists (trained care advisor model), and telehealth platforms (Teladoc TDOC, Brightside Health) expanding into geriatric and cognitive care for dementia family support services. The dementia care market is structurally underserved — 6.7 million Americans living with Alzheimer's in 2023 creates a massive caregiver support need that traditional healthcare systems provide inadequately. Johns Hopkins MIND at Home validation provides clinical credibility for Craniometrix's care model. Y Combinator backing connects Craniometrix with the digital health and elder care technology investor community. The 2025 strategy focuses on health plan partnerships (Medicare Advantage plans with CHRONIC Care Act chronic care management billing), employer benefit channels (employees managing parent dementia care), and growing the behavioral symptom management coaching that reduces caregiver burnout and emergency utilization.

Revenue
$6.5M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Craniometrix is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Not So Random Others

AbbVie

Healthcare
AnalyticsB2bEnterpriseGlobalHealthtechPublic

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp

Zeffy

Nonprofit Tech
B2bSaas

Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs

Oda Studio

Real Estate & Property Tech
B2bProptechAi PoweredSaas

Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Cursor

Developer Tools & Platforms
B2bDeveloper ToolsSaasUnicorn

Cursor is an AI-powered code editor built on Visual Studio Code that integrates advanced language models to provide intelligent code completion, generation, debugging, and refactoring capabilities dir

Compare Craniometrix with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Craniometrix

Claim This Profile

Are you from Craniometrix? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Craniometrix Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Craniometrix vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →